Endogenous α-Synuclein Is Induced by Valproic Acid through Histone Deacetylase Inhibition and Participates in Neuroprotection against Glutamate-Induced Excitotoxicity
Authors:
Open Access
- 12 July 2006
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 26 (28) , 7502-7512
Abstract
Emerging evidence suggests that α-synuclein (α-syn), which is traditionally thought to have a pathophysiological role in neurodegenerative diseases, can have neuroprotective effects. This study aimed to investigate whether endogenous α-syn in neurons can be induced by valproic acid (VPA), a mood-stabilizer, anticonvulsant and histone deacetylase (HDAC) inhibitor, and if so, whether the α-syn induction is neuroprotective. VPA treatment of rat cerebellar granule cells caused a robust dose- and time-dependent increase in levels of α-syn protein and mRNA and in the intensity of α-syn immunostaining. Knockdown of VPA-induced α-syn overexpression with α-syn antisense oligonucleotides or siRNA completely blocked VPA-induced neuroprotection. α-Syn knockdown also exacerbated glutamate neurotoxicity, stimulated the expression of the proapoptotic gene ubiquitin-conjugating enzyme E2N, and downregulated the expression of the anti-apoptotic gene Bcl-2. Induction of α-syn by VPA was associated with inhibition of HDAC activity, resulting in hyperacetylation of histone H3 in the α-syn promoter and a marked increase in α-syn promoter activity. Moreover, VPA-induced α-syn induction and neuroprotection were mimicked by HDAC inhibitors sodium 4-phenylbutyrate and trichostatin A (TSA). α-syn was also induced by VPA in rat cerebral cortical neurons. Additionally, treatment of rats with VPA, sodium butyrate, or TSA markedly increased α-syn protein levels in the cortex and cerebellum. Together, our results demonstrate for the first time that VPA induces α-syn in neurons through inhibition of HDAC and that this α-syn induction is critically involved in neuroprotection against glutamate excitotoxicity. Clinically, VPA may represent a suitable treatment for excitotoxicity-related neurodegenerative diseases.Keywords
This publication has 54 references indexed in Scilit:
- α-Synuclein Cooperates with CSPα in Preventing NeurodegenerationCell, 2005
- α‐Synuclein produces a long‐lasting increase in neurotransmitter releaseThe EMBO Journal, 2004
- Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neuronsThe Pharmacogenomics Journal, 2004
- BDNF is induced by wild-type α-synuclein but not by the two mutants, A30P or A53T, in glioma cell lineBiochemical and Biophysical Research Communications, 2004
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- α-Synuclein Protects against Oxidative Stress via Inactivation of the c-Jun N-terminal Kinase Stress-signaling Pathway in Neuronal CellsJournal of Biological Chemistry, 2002
- α-Synuclein Membrane Interactions and Lipid SpecificityJournal of Biological Chemistry, 2000
- The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNSJournal of Neurochemistry, 1999
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997